Adobe
ADBE
Netflix
NFLX
Meta Platforms
META
Alphabet-A
GOOGL
Alphabet-C
GOOG
US Stock MarketDetailed Quotes
VVOS Vivos Therapeutics
- 3.4700
- -0.2400-6.47%
Trading Mar 25 13:02 ET
20.44MMarket Cap-0.70P/E (TTM)
3.7687High3.3608Low51.39KVolume3.6500Open3.7100Pre Close185.09KTurnover0.92%Turnover RatioLossP/E (Static)5.89MShares6.280052wk High2.67P/B19.31MFloat Cap1.910052wk Low--Dividend TTM5.56MShs Float360.2500Historical High--Div YieldTTM11.00%Amplitude1.9100Historical Low3.6010Avg Price1Lot Size
Vivos Therapeutics Key Stats
EPS
According to the latest financial report of Vivos Therapeutics, the latest earnings per share (TTM) for the company is -0.40. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: USD
Quarterly
Loading...
FCF
Interested in knowing about Vivos Therapeutics's free cash flow? The latest report shows it as -4.38M. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.
Currency: USD
Quarterly
Loading...
Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Vivos Therapeutics shows that the company's current ratio is 1.44, indicating healthy liquidity.
Currency: USD
Quarterly
Loading...
Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Vivos Therapeutics, the quick ratio is 1.32, indicating that the company can meet its short-term debt obligations.
Currency: USD
Quarterly
Loading...
ROE
Want to learn more about the financial health of Vivos Therapeutics? The latest ROE figure is -37.34%, indicating that the company has stable profitability.
Currency: USD
Quarterly
Loading...
ROA
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Vivos Therapeutics, the total asset return on investment (ROA) is -16.78%.
Currency: USD
Quarterly
Loading...
Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check Vivos Therapeutics's latest financial report to see how their gross margin is doing - currently at 60.47%.
Currency: USD
Quarterly
Loading...
Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Vivos Therapeutics, the net profit margin is -67.77%, which is a good sign for its profitability.
Currency: USD
Quarterly
Loading...
Market Insights
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.